Medlab Clinical $6.600
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:20am | ||||
MEDLAB CLINICAL LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
Notice of Annual General Meeting/Proxy Form
MDC released this announcement to the ASX on 14 September 2021, 15:43. The announcement is not marked as price sensitive, and is 21 page(s) in length and 705.25kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Notice of Annual General Meeting/Proxy Form | 14 September 2021, 15:43 |
| MDC Presentation - Update and Future Initiatives | 3 September 2021, 8:32 |
| Appendix 4G | 31 August 2021, 8:38 |
| Corporate Governance Statement | 31 August 2021, 8:21 |
If you were already registered, log in here.
If you were already registered, log in here.